A REVIEW OF FEMA 4774

Notwithstanding a variety of setbacks, quite a few MDM2 inhibitors have now progressed into late-stage clinical advancement. New techniques have also been produced to boost the efficacy of MDM2 inhibitors and also to mitigate their on-concentrate on toxicity. During this review, we summarize the progress and problems in the development of a MDM2 ta